Question

. Which of the following statement is/are correct about Favipiravir?

Favipiravir is an antiviral COVID-19 drug.

Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir.

It is India's first COVID-19 drug launched, priced at Rs 103 per tablet.

All the above are correct

Clear selection


​

Answer 1

Explanation:

thank my answers I had thanked ur answers

Answer 2

We are given a few sentences about Favipiravir and we have to say which option is correct

• The correct answer to the statement asked is Favipiravir is an antiviral Covid drug which is the first option given
• The second sentence is ' Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir' is false as the drug was made under the brand Bal Pharma
• The third sentence given is ' It is India's first COVID-19 drug launched, priced at Rs 103 per tablet ' is false because even though it is India's first Covid - 19 drug launched the price of the tablet is only Rs.85
• The fourth sentence is also false as the above two options are wrong
• So the correct answer to the question is 'Favipiravir is an antiviral COVID-19 drug. '